ReviewFrontiers in plant science2017
Review in Frontiers in plant science, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed.
- Identification and characterization of Phi1 and Phi3 bacteriophages targeting Xylella fastidiosa subsp. pauca, the causal agent of olive quick decline in Italy.Scientific reports · 2026Article
- Development of a novel, rapid, and accurate recombinase polymerase amplification assay for the identification of the glassy-winged sharpshooter,3 Biotech · 2025Article
- Projecting the global spread of xylella fastidiosa under climate change using maxent modeling.Scientific reports · 2025Article
- A systems biology framework integrating cross-species transcriptomics and PPI networks for Xylella fastidiosa resistance gene identification.BMC plant biology · 2025Article
- BDSF Analogues Inhibit Quorum Sensing-Regulated Biofilm Production inMicroorganisms · 2024Article
- Sensitivity of Xylella fastidiosa subsp. pauca Salento-1 to light at 410 nm.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2024Article
- Evidence ofPlants (Basel, Switzerland) · 2023Article
- Xylem Embolism and Pathogens: Can the Vessel Anatomy of Woody Plants Contribute toPathogens (Basel, Switzerland) · 2023Review
- Phytosanitary Rules for the Movement of Olive (Plants (Basel, Switzerland) · 2023Review
- Bactericidal and plant defense elicitation activities of Eucalyptus oil decrease the severity of infections byFrontiers in plant science · 2023Article
- Xylella fastidiosa in Europe: From the Introduction to the Current Status.The plant pathology journal · 2022Review
- Synthetic Peptides against Plant Pathogenic Bacteria.Microorganisms · 2022Review
- Systematic assessment of template-based genome-scale metabolic models created with the BiGG Integration Tool.Journal of integrative bioinformatics · 2022Article
- Identification and validation of SSR markers for3 Biotech · 2022Article
- Investigating plant disease outbreaks with long-read metagenomics: sensitive detection and highly resolved phylogenetic reconstruction applied toMicrobial genomics · 2022Article
- Development of a CAPS Marker and a LAMP Assay for Rapid Detection ofInternational journal of molecular sciences · 2022Article
- Expression of putative effectors of different Xylella fastidiosa strains triggers cell death-like responses in various Nicotiana model plants.Molecular plant pathology · 2022Article
- Article
- Complete Genome Sequence ofFrontiers in microbiology · 2021Article
- Antimicrobial Peptides With Antibiofilm Activity AgainstFrontiers in microbiology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the never ending struggle against plant pathogenic bacteria, a major goal is the early identification and classification of infecting microorganisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.